The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $24,394,304.49 cost-plus-fixed-fee contract to Digital Infuzion, LLC, a minority-owned IT services company, to provide coordination, communication, and operations support for the NCATS Clinical and Translational Science Awards (CTSA) Program. The CTSA Program is a national consortium of medical research institutions that collaborate to accelerate the translation of discoveries into clinical interventions. The contract has a five-year period of performance and does not have a set-aside designation. Digital Infuzion will be responsible for data collection and analysis, fostering communication, and strengthening collaboration among CTSA Program participants and stakeholders to support the program's strategic goals.
Generated 11/27/24, 9:10 AM